Visual outcomes of scleral-fixated posterior chamber intraocular lenses in children with genetic ectopia lentis: long-term follow-up - Scorecard - MDSpire

Visual outcomes of scleral-fixated posterior chamber intraocular lenses in children with genetic ectopia lentis: long-term follow-up

  • By

  • Kevin Vallotton

  • Oussama Habra

  • Beatrice E. Frueh

  • June 8, 2026

  • 0 min

Share

Clinical Scorecard: Long-term Visual Outcomes in Children with Genetic Ectopia Lentis Following Scleral-Fixated Posterior Chamber Intraocular Lens Surgery

At a Glance

CategoryDetail
ConditionEctopia lentis
Key MechanismsDisplacement of the crystalline lens leading to visual impairment, often associated with systemic disorders like Marfan syndrome.
Target PopulationPediatric patients under 12 years with non-traumatic ectopia lentis.
Care SettingOphthalmic surgical setting.

Key Highlights

  • Scleral-fixated intraocular lenses (IOLs) provide stable optical correction.
  • Surgical management varies based on lens subluxation and capsular integrity.
  • Targeting mild postoperative hyperopia accommodates expected ocular growth.

Guideline-Based Recommendations

Diagnosis

  • Genetic testing for conditions like Marfan syndrome and other etiologies of ectopia lentis.

Management

  • Scleral-fixated IOL implantation is preferred over leaving the child aphakic.

Monitoring & Follow-up

  • Long-term follow-up to assess visual outcomes and potential complications.

Risks

  • Potential for amblyopia, late suture loosening, or IOL dislocation requiring reoperation.

Patient & Prescribing Data

Children under 12 years with significant lens displacement.

IOL power calculated using the SRK/T formula based on preoperative axial length.

Clinical Best Practices

  • Individualize target refraction based on age and projected ocular growth.
  • Utilize standardized surgical techniques for IOL implantation.

Related Resources & Content

Original Source(s)

Visual outcomes of scleral-fixated posterior chamber intraocular lenses in children with genetic ectopia lentis: long-term follow-up

  • by Kevin Vallotton, Oussama Habra, Beatrice E. Frueh

  • June 8, 2026

Related Content

Haag-Streit Announces Appointment of New CCO

Anette Chauhan will lead the company’s global commercial activities and organization

  • June 29, 2026

  • 1 min
Phenotype-driven management of diabetic macular edema: multimodal imaging biomarkers and individualized therapy

New CEO for Optos

Optos appoints Alexandre Montague as Chief Executive Officer

  • June 26, 2026

  • 2 min